Search
Displaying Results For:
Jun 08, 2026
New NIH-Funded Trial Tests Different Approaches to Long COVID Fatigue
A new NIH-funded clinical trial will test whether rehabilitation and pacing strategies should be tailored based on post-exertional malaise in people with Long COVID.
- Long COVID
- ME/CFS
- Research Studies
Jun 01, 2026
Long Covid Symptoms Vary Between Hospital and Home Patients
A new study from Italy found that long COVID remains a significant health concern years after SARS-CoV-2 infection, with the risk varying substantially depending on whether patients required hospitalization during their initial illness. Researchers followed 1,162 adults who contracted COVID-19 between 2020 and 2022, including 616 patients managed in the community and 546 hospitalized patients. […]
- Infections
- Long COVID
- Research Studies
May 20, 2026
Long COVID Study Links Fatigue to Mitochondrial Dysfunction
Researchers have identified persistent mitochondrial dysfunction and immune dysregulation as recurring biological features of long COVID, offering new clues about why symptoms such as fatigue, exercise intolerance, brain fog, and muscle weakness can linger long after the initial infection has resolved. In a new multi-omics study published in Frontiers in Immunology, scientists analyzed transcriptomic, proteomic, and […]
- Infections
- Long COVID
- ME/CFS
- Research Studies
May 13, 2026
Could Herpes Zoster Signal Post-COVID Immune Dysfunction?
Researchers analyzing health records from more than 110,000 COVID-19 survivors found that people who later experienced herpes zoster reactivation were more likely to develop certain neurological conditions, including Bell’s palsy, Guillain-Barré syndrome (GBS), and myasthenia gravis (MG), during the following three years. The timing of these conditions differed. Bell’s palsy tended to appear relatively soon […]
- Guillain-Barré syndrome
- Infections
- Myasthenia gravis
- Research Studies
May 05, 2026
Autoimmune-Associated PTPN22 Variant May Improve Immune Defense Against Covid
A recent study found that a common mutation that’s associated with a higher risk of developing autoimmune diseases is also linked to protection from viral infections. This mutation in the PTPN22 gene is called the PTPN22 1858C>T allele and is found in 5-15% of people in North America. It is considered the highest non-HLA risk […]
- Autoimmune Diseases
- Infections
- Research Studies
Apr 30, 2026
Autoimmune Drugs May Prolong COVID Viral Signals
A new study suggests that people with systemic autoimmune rheumatic diseases (SARDs) may retain pieces of the COVID-19 virus in their bodies for longer periods after infection, particularly if they are taking immunosuppressive medications. Researchers found that 40% of patients with autoimmune rheumatic diseases still had detectable SARS-CoV-2 antigens in their blood three months after […]
- Antibodies
- Autoimmune Diseases
- Infections
- Long COVID
- Research Studies
Apr 16, 2026
What New Research Reveals About Long COVID
New studies suggest Long COVID may be driven by persistent inflammation and immune disruption, helping explain why symptoms can last months or even years after infection.
- Infections
- Long COVID
- Research Studies
Mar 24, 2026
Long COVID Symptoms Linked to Autoantibodies
A new study published in Cell Reports Medicine provides some of the strongest evidence to date that antibodies may play a direct role in Long COVID symptoms. Researchers found that immunoglobulin G (IgG) antibodies taken from Long COVID patients caused persistent pain-like sensitivity when transferred into mice, suggesting these antibodies may actively contribute to the condition rather […]
- Antibodies
- Infections
- Long COVID
- Research Studies